| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.44 | 2e-43 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-21 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-20 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.4 | 4e-16 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-15 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-14 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.35 | 2e-12 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.25 | 4e-09 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |